[go: up one dir, main page]

WO2003097021A3 - Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea - Google Patents

Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea Download PDF

Info

Publication number
WO2003097021A3
WO2003097021A3 PCT/IB2003/002048 IB0302048W WO03097021A3 WO 2003097021 A3 WO2003097021 A3 WO 2003097021A3 IB 0302048 W IB0302048 W IB 0302048W WO 03097021 A3 WO03097021 A3 WO 03097021A3
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
treatment
primary dysmenorrhea
topical systems
transdermal topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2003/002048
Other languages
French (fr)
Other versions
WO2003097021A2 (en
Inventor
Stefano Camponovo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TECHNIPHARMA LLC
Original Assignee
TECHNIPHARMA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TECHNIPHARMA LLC filed Critical TECHNIPHARMA LLC
Priority to AU2003230136A priority Critical patent/AU2003230136A1/en
Publication of WO2003097021A2 publication Critical patent/WO2003097021A2/en
Publication of WO2003097021A3 publication Critical patent/WO2003097021A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The use of transdermal administration systems of non-steroidal anti-inflammatory drugs (NSAIDs) in the prevention and treatment of painful symptoms associated with primary dysmenorrhea is described.
PCT/IB2003/002048 2002-05-21 2003-05-15 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea Ceased WO2003097021A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003230136A AU2003230136A1 (en) 2002-05-21 2003-05-15 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI001078A ITMI20021078A1 (en) 2002-05-21 2002-05-21 USE OF TOPICAL TRANSDERMAL SYSTEMS FOR THE PREVENTION AND TREATMENT OF PRIMARY DYSMENORRHEA
ITMI2002A001078 2002-05-21

Publications (2)

Publication Number Publication Date
WO2003097021A2 WO2003097021A2 (en) 2003-11-27
WO2003097021A3 true WO2003097021A3 (en) 2004-01-29

Family

ID=11449935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/002048 Ceased WO2003097021A2 (en) 2002-05-21 2003-05-15 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea

Country Status (3)

Country Link
AU (1) AU2003230136A1 (en)
IT (1) ITMI20021078A1 (en)
WO (1) WO2003097021A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0907168A2 (en) * 2008-05-21 2019-09-24 Teikoku Pharma Usa Inc use of a non-steroidal anti-inflammatory drug, transdermal non-steroidal anti-inflammatory drug composition and kit to treat dysmenorrhea, as well as non-steroidal anti-inflammatory drug.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US20010038861A1 (en) * 1999-12-16 2001-11-08 Tsung-Min Hsu Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
WO2002002086A1 (en) * 2000-07-05 2002-01-10 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloranilino)-phenyl!-ethanoic acid
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
DE10049225A1 (en) * 2000-09-28 2002-04-11 Labtec Gmbh Dermal therapeutic system comprises diclofenac sodium in an acrylate copolymer matrix on a polyester web

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US20010038861A1 (en) * 1999-12-16 2001-11-08 Tsung-Min Hsu Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
WO2002002086A1 (en) * 2000-07-05 2002-01-10 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloranilino)-phenyl!-ethanoic acid
DE10049225A1 (en) * 2000-09-28 2002-04-11 Labtec Gmbh Dermal therapeutic system comprises diclofenac sodium in an acrylate copolymer matrix on a polyester web

Also Published As

Publication number Publication date
ITMI20021078A1 (en) 2003-11-21
WO2003097021A2 (en) 2003-11-27
AU2003230136A1 (en) 2003-12-02
ITMI20021078A0 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
WO2002000167A3 (en) Modified forms of pharmacologically active agents and uses therefor
WO2002089791A3 (en) Acne treatment with lipooxigenase inhibitors
ATE277596T1 (en) TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A CHOLINERGIC ACT OR A CALCIUM CHANNEL BLOCKER
EP1177793A8 (en) Inhalable medicinal aerosol composition for pain treatment or prevention
TR200002951T2 (en) (4-Arylsulphonylamino) -tetrahydropyran-4-carboxylic acid hydroxamides
WO2002085327A3 (en) Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract
AU2003243719A1 (en) Topical administration of pharmacologically active bases in the treatment of warts
BR0002607A (en) Quickly absorbed liquid compositions
WO2003024433A3 (en) Compositions for treatment of common cold, comprising ipratropium and xylometazoline
WO2002045752A3 (en) Dermal anti-inflammatory composition
AU4451501A (en) Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof
NO993670D0 (en) Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as a drug for the treatment of AIDS
AU2002357063A1 (en) Novel topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
WO2006004449A3 (en) A combination composition
EP1356815A4 (en) PAIN-RELIEF AND ANTI-INFLAMMATORY ACTIVE SUBSTANCES
WO2003066130A3 (en) Transdermal drug delivery systems
AU2002332488A1 (en) R-bambuterol, its preparation and therapeutic uses
WO2005039483A3 (en) Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
WO1998055118A3 (en) Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
WO2003097021A3 (en) Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea
BR9910201A (en) Transdermal therapeutic system for the use of candesartan
AU2002354901A1 (en) Compounds with analgesic, antipyretic and/or anti-inflammatory activity
WO2002069968A8 (en) New use
AR004330A1 (en) USE OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF XEROSTOMY

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP